When it comes to Ebola outbreaks, it's not often we have two pieces of good news in one week.

In der Demokratischen Republik Kongo grassiert ein Ebolavirus, gegen das es weder Impfstoffe noch Medikamente gibt. Forschende hoffen, schon bald erste Mittel an Menschen testen…

Vaccine development can be really expensive, and there’s limited commercial return.

When it comes to Ebola outbreaks, it's not often we have two pieces of good news in one week.